Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05289245

A National Registry on Chinese Patients With Cystic Fibrosis

A National Registry on Clinical Manifestations, Genetics, Interventions, and Outcomes in Chinese Patients With Cystic Fibrosis (CF-CHINA)

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Peking Union Medical College Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Cystic fibrosis (CF) is a rare autosomal recessive disease involving multiple organs, especially the lungs and digestive organs. It is most commonly seen in Caucasians. Only a few Chinese CF patients have been described in literature, taking into account the large population of China. The main objectives of this study are to accurately evaluate the prevalence of CF, the status of disease, the diagnosis and treatment, the quality of care, and the health related outcomes in China.

Conditions

Timeline

Start date
2022-04-01
Primary completion
2032-10-01
Completion
2032-10-01
First posted
2022-03-21
Last updated
2022-03-21

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05289245. Inclusion in this directory is not an endorsement.